Mary Straub

Title: Mary Straub - Innovator in Biochemical Therapeutics

Introduction

Mary Straub is a distinguished inventor based in Malibu, California. She has made significant contributions to the field of biochemistry, particularly in the development of therapeutic solutions for diseases related to phenylalanine imbalance. Her innovative work has garnered attention in both academic and pharmaceutical circles.

Latest Patents

Mary Straub holds 1 patent for her invention titled "Variants and chemically-modified variants of phenylalanine ammonia-lyase." This invention focuses on the use of the protein phenylalanine ammonia-lyase and its biologically-active derivatives for preventing or treating diseases associated with phenylalanine imbalance in humans and animals. The patent outlines therapeutic compositions that include a pharmaceutically active amount of these molecules and methods for selecting more therapeutically effective variants of the protein.

Career Highlights

Throughout her career, Mary has worked with prominent organizations such as the Scripps Research Institute and BioMarin Pharmaceutical Inc. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Mary has collaborated with notable colleagues, including Marianne Patch and Paul Andrew Fitzpatrick. These partnerships have enriched her research and expanded the impact of her inventions.

Conclusion

Mary Straub's innovative work in the field of biochemistry exemplifies the importance of research in developing therapeutic solutions for health challenges. Her contributions continue to influence the scientific community and pave the way for future advancements.